Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Human Papillomavirus Vaccination Over Time in Heterosexual and Sexual Minority Adults in the United States. Health equity Chan, C., Mann, A. K., Lee, D., Nutkiewicz, L., Watson, K. T., Kapp, D. S., Obedin-Maliver, J. 2022; 6 (1): 307-312

Abstract

We proposed to identify the factors that determine the trends in human papillomavirus (HPV) vaccination initiation and completion among heterosexual and sexual minority adults.Using National Health and Nutrition Examination Survey database from 2007 to 2016, we performed chi-squared tests and multivariate logistic regression analysis.Heterosexual females initiated vaccination at 23.5% compared with sexual minority females at 34.6% (p<0.001). Although heterosexual males also had a lower vaccination initiation than sexual minority males (7.7% vs. 15.5%; p=0.12), their completion rate appeared higher (38% vs. 17%; p=0.14).Interventions are needed to enhance support for completion rates of HPV vaccine among sexual minority individuals.

View details for DOI 10.1089/heq.2021.0058

View details for PubMedID 35557550

View details for PubMedCentralID PMC9081066